Macrofocal multiple myeloma in young patients: A distinct entity with favorable prognosis

Leukemia and Lymphoma

Volumn 47, Issue 8, 2006, Pages 1553-1556

  Dimopoulos, Meletios Athanasios ^a   Pouli, Anastasia ^b   Anagnostopoulos, Athanasios ^a   Repoussis, Panagiotis ^c   Symeonidis, Argyris ^d   Terpos, Evangelos ^e   Delimbasi, Sosana ^f   Tsolakis, Friderikos ^g   Economopoulos, Theophanis ^a   Zervas, Constantinos ^h  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Department of Hematology   (Greece)

^c METAXA CANCER HOSPITAL   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

^e General Air Force Hospital   (Greece)

^f EVANGELISMOS HOSPITAL   (Greece)

^g Department of Hematology   (Greece)

^h THEAGENIO CANCER HOSPITAL   (Greece)

Author keywords

Macrofocal; Myeloma; Prognosis; Young age

Indexed keywords

ALKYLATING AGENT; CORTICOSTEROID; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN; LACTATE DEHYDROGENASE; VINCRISTINE;

ADULT; ANEMIA; ARTICLE; BONE LESION; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; HYPERCALCEMIA; KIDNEY DISEASE; LABORATORY TEST; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STEM CELL TRANSPLANTATION;

ADULT; ANEMIA; HUMANS; KIDNEY DISEASES; MULTIPLE MYELOMA; OSTEOLYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR BURDEN;

EID: 33748519245     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190600647723     Document Type: Article

References (10)

1. Kyle, R and Rajkumar, S. (2004) Multiple myeloma N Engl J Med, 351, pp. 1860-1873.
2. Hewell, G and Alexanian, R. (1976) Multiple myeloma in young persons Ann Intern Med, 84, pp. 441-443.
3. Rapoport, A and Rowe, J. (1990) Plasma cell dyscrasia in a 15-year-old boy: Case report and review of the literature Am J Med, 89, pp. 816-818.
4. Ishida, T and Dorfman, H. (1995) Plasma cell myeloma in unusually young patients: A report of two cases and review of the literature Skeletal Radiol, 24, pp. 47-51.
5. Blade, J and Kyle, R and Greipp, P. (1996) Multiple myeloma in patients younger than 30 years Arch Intern Med, 156, pp. 1463-1468.
6. Chen, C and Gan, J and Ho, C and Lin, J and Chiou, H and Lirng, J. (2003) Aggressive multiple myeloma with brain involvement in a young patient J Clin Med Assoc, 66, pp. 177-180.
7. Greipp, P and San Miguel, J and Durie, B and Crowley, J and Barlogie, B and Blade, J and (2005) International staging system for multiple myeloma J Clin Oncol, 23, pp. 3412-3420.
8. Blade, J and Samson, D and Reece, D and Apperley, J and Bjorkstrand, B and Gharton, J and (1998) Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma subcommittee of the EBMT Br J Haematol, 102, pp. 1115-1123.
9. Dimopoulos, M and Moulopoulos, L and Maniatis, A and Alexanian, R. (2000) Solitary plasmacytoma of bone and asymptomatic mutliple myeloma Blood, 96, pp. 2037-2044.
10. Bergsagel, P and Kuehl, W and Zhan, F and Sawyer, J and Barlogie, B and Shaughnessy, J. (2005) Cyclin D dysregulation: An early and unifying pathogenic event in multiple myeloma Blood, 106, pp. 296-303.